SFDAのCEO、米国で先進医療分野における世界のベストプラクティスを視察

SFDA CEO explores global best practices in advanced therapies in US

SFDA CEO Aljadhey toured US centers to learn CAR-T cell and gene-editing manufacturing practices. The move signals Saudi Arabia's strategy to build domestic regulatory expertise for advanced therapies, accelerating biotech innovation adoption and positioning the Kingdom as a regional hub.